Review of the pathogenesis, diagnosis, and management of type i gastric carcinoid tumor

World Journal of Surgery

Volumn 35, Issue 8, 2011, Pages 1879-1886

  Zhang, Linda ^a   Ozao, Junko ^a   Warner, Richard ^a   Divino, Celia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN;

ATROPHIC GASTRITIS; BLOOD; CANCER STAGING; CARCINOID; ENTEROCHROMAFFIN CELL; GASTRECTOMY; GASTROSCOPY; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYP; PROGNOSIS; REVIEW; RISK FACTOR; SCINTISCANNING; STOMACH ANTRUM; STOMACH FUNDUS; STOMACH MUCOSA; STOMACH PH; STOMACH TUMOR;

CARCINOID TUMOR; ENTEROCHROMAFFIN CELLS; GASTRECTOMY; GASTRIC ACIDITY DETERMINATION; GASTRIC FUNDUS; GASTRIC MUCOSA; GASTRINS; GASTRITIS, ATROPHIC; GASTROSCOPY; HUMANS; NEOPLASM STAGING; POLYPS; PROGNOSIS; PYLORIC ANTRUM; RADIONUCLIDE IMAGING; RISK FACTORS; STOMACH NEOPLASMS;

EID: 80051553826     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-011-1137-0     Document Type: Review

References (48)

1. IM Modlin KD Lye M Kidd 2004 A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol 99 23 32 14687136 10.1046/j.1572-0241.2003.04027.x (Pubitemid 38679096)
2. R Gencosmanoglu E Sen-Oran O Kurtkaya-Yapicier, et al. 2003 Gastric polypoid lesions: analysis of 150 endoscopic polypectomy specimens from 91 patients World J Gastroenterol 9 2236 2239 14562385 (Pubitemid 37321452)
3. GF Dakin RR Warner A Pomp, et al. 2006 Presentation, treatment, and outcome of type 1 gastric carcinoid tumors J Surg Oncol 93 5 368 372 16550587 10.1002/jso.20468
4. K Borch B Ahrén H Ahlman, et al. 2005 Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type Ann Surg 242 1 64 73 15973103 10.1097/01.sla.0000167862.52309.7d (Pubitemid 40917969)
5. O Hosokawa Y Kaizaki M Hattori, et al. 2005 Long-term follow-up of patients with multiple gastric carcinoids associated with type A gastritis Gastric Cancer 8 42 46 15747174 10.1007/s10120-004-0303-6 (Pubitemid 40394925)
6. DB Gough GB Thompson TB Crotty, et al. 1994 Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia World J Surg 18 4 473 479 7725731 10.1007/BF00353739 1:STN:280: DyaK2M3kt1OltA%3D%3D discussion 479-480
7. B Annibale C Azzoni VD Corleto, et al. 2001 Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid Eur J Gastroenterol Hepatol 13 1449 1456 11742193 10.1097/00042737-200112000-00008 1:STN:280:DC%2BD3MjgtV2lsg%3D%3D (Pubitemid 33151497)
8. IM Modlin KD Lye M Kidd 2003 Carcinoid tumors of the stomach Surg Oncol 12 153 172 12946486 10.1016/S0960-7404(03)00034-3 (Pubitemid 37289020)
9. T D'Adda G Keller C Bordi, et al. 1999 Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome Lab Invest 79 671 677 10378509 (Pubitemid 29283420)
10. SK Agarwal PA Kennedy PC Scacheri, et al. 2005 Menin molecular interactions: insights into normal functions and tumorigenesis Horm Metab Res 37 369 374 16001329 10.1055/s-2005-870139 1:CAS:528:DC%2BD2MXmslGjs7o%3D (Pubitemid 41008771)
11. AD Higham LA Bishop R Dimaline, et al. 1999 Mutations of RegIalpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia Gastroenterology 116 1310 1318 10348814 10.1016/S0016-5085(99) 70495-6 1:STN:280:DyaK1M3nvVantg%3D%3D (Pubitemid 29258879)
12. E Solcia R Fiocca L Villani, et al. 1995 Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis Am J Surg Pathol 19 Suppl 1 S1 S7 7762735
13. AV Safatle-Ribeiro U Ribeiro Jr CE Corbett, et al. 2007 Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors Eur J Gastroenterol Hepatol 19 1 21 28 17206073 10.1097/01.meg.0000250582.30737.bd 1:CAS:528:DC%2BD2sXhvFWitA%3D%3D (Pubitemid 46066864)
14. J Kagawa S Honda M Kodama, et al. 2002 Enterochromaffin-like cell tumor induced by Helicobacter pylori infection in Mongolian gerbils Helicobacter 7 390 397 12485127 10.1046/j.1523-5378.2002.00115.x (Pubitemid 36068500)
15. LH Tang EA Luque JA Efstathiou, et al. 1997 Gastrin receptor expression and function during rapid transformation of the enterochromaffin-like cells in an African rodent Regul Pept 72 9 18 9404728 10.1016/S0167-0115(97)01025-2 1:CAS:528:DyaK2sXntVyjsbs%3D (Pubitemid 27492058)
16. S Sjoblom 1988 Clinical presentation and prognosis of gastrointestinal carcinoid tumors Scand J Gastroenterol 23 779 787 3227292 10.3109/ 00365528809090760 1:STN:280:DyaL1M7ksF2ruw%3D%3D
17. S Rappel A Altendorfhofmann M Stolte 1995 Prognosis of gastric carcinoid tumors Digestion 56 455 462 8536814 10.1159/000201276 1:STN:280: DyaK287islGisg%3D%3D
18. Solcia E, Klöppel G, Sobin LH et al (1999) Histological typing of endocrine tumours. Springer, Berlin
19. C Bordi JY Yu MT Baggi, et al. 1991 Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases Cancer 67 663 672 1702355 10.1002/1097-0142(19910201)67:3<663::AID- CNCR2820670323>3.0.CO;2-L 1:STN:280:DyaK3M%2FptFyiuw%3D%3D
20. K Oberg 1996 Neuroendocrine gastrointestinal tumours Ann Oncol 7 5 453 463 8839899 1:STN:280:DyaK28vjslSrtw%3D%3D (Pubitemid 26232950)
21. D Granberg E Wilander M Stridsberg, et al. 1998 Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids Gut 43 2 223 228 10189848 10.1136/gut.43.2.223 1:STN:280:DyaK1M3gsFyntA%3D%3D (Pubitemid 28348325)
22. FR Nobels DJ Kwekkeboom W Coopmans, et al. 1997 Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones J Clin Endocrinol Metab 82 8 2622 2628 9253344 10.1210/jc.82.8.2622 1:CAS:528:DyaK2sXltFGmsrc%3D (Pubitemid 27337883)
23. D Campana F Nori R Pezzilli, et al. 2008 Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs Endocr Relat Cancer 15 1 337 342 18310299 10.1677/ERC-07-0251 1:CAS:528:DC%2BD1cXkslKnu7c%3D (Pubitemid 351449751)
24. V Fykse AK Sandvik G Qvigstad, et al. 2004 Treatment of ECL cell carcinoids with octreotide LAR Scand J Gastroenterol 39 7 621 628 15370681 10.1080/00365520410005225 1:CAS:528:DC%2BD2cXmslCgtLg%3D (Pubitemid 38916236)
25. W Shi CF Johnston KD Buchanan, et al. 1998 Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging QJM 91 4 295 301 9666953 10.1093/qjmed/91.4.295 1:STN:280:DyaK1czjtFGkug%3D%3D (Pubitemid 28161912)
26. H Rehm B Wiedenmann H Betz 1986 Molecular characterization of synaptophysin, a major calcium-binding protein of the synaptic vesicle membrane EMBO J 5 535 541 3086086 1:CAS:528:DyaL28XhvVWqurY%3D
27. JD Erickson MK Schafer TI Bonner, et al. 1996 Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter Proc Natl Acad Sci USA 93 5166 5171 8643547 10.1073/pnas.93.10.5166 1:CAS:528:DyaK28XjtVKlu7k%3D (Pubitemid 26162890)
28. G Rindi D Paolotti R Fiocca, et al. 2000 Vesicular monoamine transporter 2 as a marker of gastric enterochromaffin-like cell tumors Virchows Arch 436 217 223 10782879 10.1007/s004280050033 1:CAS:528:DC%2BD3cXhsFShs7c%3D (Pubitemid 30168679)
29. EP Krenning DJ Kwekkeboom HY Oei, et al. 1994 Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results Ann N Y Acad Sci 733 416 424 7978890 10.1111/j.1749-6632.1994.tb17291.x 1:CAS:528:DyaK2MXjvFWru7o%3D
30. RR Warner TM O'Dorisio 2002 Radiolabeled peptides in diagnosis and tumor imaging: clinical overview Semin Nucl Med 32 2 79 83 11965602 10.1053/snuc.2002.31020 (Pubitemid 34311073)
31. F Gilbrit JC Reynolds SA Lubensky, et al. 2000 Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids; a prospective study J Nucl Med 41 1646 1656
32. AJ Eckardt W Wassef 2005 Diagnosis of subepithelial tumors in the GI tract. Endoscopy, EUS, and histology: bronze, silver, and gold standard? Gastrointest Endosc 62 2 209 212 16046980 10.1016/j.gie.2005.05.001 (Pubitemid 41021543)
33. J Ichikawa S Tanabe W Koizumi, et al. 2003 Endoscopic mucosal resection in the management of gastric carcinoid tumors Endoscopy 35 3 203 206 12584637 10.1055/s-2003-37256 1:STN:280:DC%2BD3s%2FntlensQ%3D%3D (Pubitemid 36292294)
34. A Chak 2002 EUS in submucosal tumors Gastrointest Endosc 56 4 Suppl S43 S48 12297748 10.1016/S0016-5107(02)70085-0
35. H Ahlman L Kolby L Lundell, et al. 1994 Clinical management of gastric carcinoid tumors Digestion 55 suppl 3 77 85 7698542 10.1159/000201206
36. AD Higham R Dimaline A Varro, et al. 1999 Octreotide suppression test predicts beneficial outcome from antrectomy in patients with gastric carcinoid tumor Gastroenterology 114 817 822 10.1016/S0016-5085(98)70596-7 (Pubitemid 28160417)
37. RF Harvey 1988 Spontaneous resolution of multifocal gastric enterochromaffin-like cell carcinoid tumours Lancet 1 8589 821 2895334 10.1016/S0140-6736(88)91677-7 1:STN:280:DyaL1c7nsVSitw%3D%3D (Pubitemid 18094930)
38. R Brundler JO Gebbers D Criblez 1999 Multiple gastric carcinoid tumors in chronic atrophic gastritis: long-term follow-up under conservative management Schweiz Med Wochenschr 129 957 960 10422191 1:STN:280:DyaK1MzltFSqsw%3D%3D (Pubitemid 29302442)
39. D Ravizza G Fiori C Trovato, et al. 2007 Long-term endoscopic and clinical follow-up of untreated type 1 gastric neuroendocrine tumours Dig Liver Dis 39 6 537 543 17433795 10.1016/j.dld.2007.01.018 1:STN:280: DC%2BD2szgtVejuw%3D%3D (Pubitemid 46746641)
40. R Gladdy V Strong C Coit, et al. 2008 Defining surgical indications for type 1 gastric carcinoid Ann Surg Oncol 15 suppl 2 50
41. CJ Gilligan GP Lawton LH Tang, et al. 1995 Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion Am J Gastroenterol 90 338 352 7872269 1:STN:280:DyaK2M7nslWisw%3D%3D
42. G Kadikoylu I Yavasoglu V Yukselen, et al. 2006 Treatment of solitary gastric carcinoid tumor by endoscopic polypectomy in a patient with pernicious anemia World J Gastroenterol 12 26 4267 4269 16830392 (Pubitemid 44376920)
43. M Schindl K Kaserer B Niederle 2001 Treatment of gastric neuroendocrine tumors: the necessity of a type-adapted treatment Arch Surg 136 49 54 11146777 10.1001/archsurg.136.1.49 1:STN:280:DC%2BD3M7hslCmtQ%3D%3D (Pubitemid 32064120)
44. S Manfredi M Pagenault AS de Lajarte-Thirouard, et al. 2007 Type 1 and 2 gastric carcinoid tumors: long-term follow-up of the efficacy of treatment with a slow-release somatostatin analogue Eur J Gastroenterol Hepatol 19 11 1021 1025 18049175 10.1097/MEG.0b013e328220eae0 (Pubitemid 350287412)
45. P Guillem 2005 Gastric carcinoid tumours. Is there a place for antrectomy? Ann Chir 130 5 323 326 15890310 10.1016/j.anchir.2005.03.010 1:STN:280:DC%2BD2M3ovFyktA%3D%3D (Pubitemid 40797749)
46. RS Yalow SA Berson 1970 Radioimmunoassay of gastrin Gastroenterology 58 1 14 5460746 1:CAS:528:DyaE3cXltFKquw%3D%3D
47. G Ferraro B Annibale M Marignani, et al. 1996 Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growth J Clin Endocrinol Metab 81 677 683 8636288 10.1210/jc.81.2.677 1:CAS:528:DyaK28XhtVyktrc%3D (Pubitemid 26055684)
48. V Fykse AK Sandvik HL Waldum 2005 One-year follow-up study of patients with enterochromaffin-like cell carcinoids after treatment with octreotide long-acting release Scand J Gastroenterol 40 11 1269 1274 16334435 10.1080/00365520510023684 (Pubitemid 41658724)